세브란스병원은 서울특별시 서대문구 신촌동에 위치한 병원이다. 연세대학교 의료원 산하의 병원이며 3차급여기관이자 대한민국의 상급종합병원이다. 1885년에 설립된 광혜원의 운영에서 시작되었다. 故 이한열 열사가 사망한 곳이기도 하다.

During the past decade, Yongdong Severance Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yongdong Severance Hospital" #1 sponsor was "Yonsei University" with 2 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Human Genome Sciences Inc." with 1 trials sponsored, "Inje University" with 1 trials sponsored and "Korean Glaucoma Society" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yongdong Severance Hospital" #1 collaborator was "Korea Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Yongdong Severance Hospital" are "Ampulla of Vater Cancer" (1 trials), "Bile Duct Cancer" (1 trials), "Cerebral Infarction" (1 trials), "Chronic Hepatitis C" (1 trials) and "Diabetic Nephropathies" (1 trials). Many other conditions were trialed in "Yongdong Severance Hospital" in a lesser frequency.

Most popular intervention types in "Yongdong Severance Hospital" are "Drug" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "Docetaxel and epirubicin" (1 trials), "Enteral Feeding and Total Parental Support" (1 trials), "Ribavirin" (1 trials) and "albumin interferon alfa-2b" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yongdong Severance Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Yongdong Severance Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Yongdong Severance Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yongdong Severance Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".